Accessibility Menu
 
Zoetis logo

Zoetis

(NYSE) ZTS

Current Price$113.47
Market Cap$47.85B
Since IPO (2013)+306%
5 Year-24%
1 Year-30%
1 Month-12%

Zoetis Financials at a Glance

Market Cap

$47.85B

Revenue (TTM)

$9.47B

Net Income (TTM)

$2.67B

EPS (TTM)

$6.02

P/E Ratio

18.82

Dividend

$2.03

Beta (Volatility)

0.83 (Low)

Price

$113.47

Volume

3,602,059

Open

$116.81

Previous Close

$113.35

Daily Range

$113.29 - $117.29

52-Week Range

$113.29 - $172.23

ZTS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Zoetis

Industry

Pharmaceuticals

Employees

14,500

CEO

Kristin C. Peck, MBA

Headquarters

Parsippany, NJ 07054, US

ZTS Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

38%

Net Income Margin

28%

Return on Equity

66%

Return on Capital

27%

Return on Assets

17%

Earnings Yield

5.31%

Dividend Yield

0.02%

Payout Ratio

33.26%

Stock Overview

Market Cap

$47.85B

Shares Outstanding

422.13M

Volume

3.60M

Short Interest

0.00%

Avg. Volume

4.50M

Financials (TTM)

Gross Profit

$6.67B

Operating Income

$3.60B

EBITDA

$4.07B

Operating Cash Flow

$2.90B

Capital Expenditure

$621.00M

Free Cash Flow

$2.28B

Cash & ST Invst.

$2.31B

Total Debt

$9.49B

Zoetis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$2.39B

+3.0%

Gross Profit

$1.64B

+4.3%

Gross Margin

68.87%

N/A

Market Cap

$47.85B

N/A

Market Cap/Employee

$3.47M

N/A

Employees

13,800

N/A

Net Income

$603.00M

+3.8%

EBITDA

$947.00M

+4.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$7.18B

-50.9%

Accounts Receivable

$1.59B

+20.8%

Inventory

$2.43B

+5.4%

Long Term Debt

$9.44B

+75.0%

Short Term Debt

$53.00M

-96.1%

Return on Assets

17.28%

N/A

Return on Invested Capital

27.18%

N/A

Free Cash Flow

$732.00M

+6.2%

Operating Cash Flow

$893.00M

-1.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDXXIDEXX Laboratories, Inc.
$558.32-2.61%
HLNHaleon plc
$9.80+0.51%
ARGXargenx SE
$691.40-0.21%
BDXBecton, Dickinson and Company
$154.51-1.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$38.78-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.28+0.05%
QQQInvesco QQQ Trust
$562.58-0.02%
ARTLArtelo Biosciences
$10.54+2.30%

Questions About ZTS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.